Abstract
Leukemia remains a major cause of death in both developing as well as developed nations worldwide. Development of novel therapeutic approaches is perceived to be the best strategy to combat this disease. Availability of limited effective drugs with least side effects is the major hurdle in treating leukemia. Another major concern remains initiation and engagement of therapeutic strategies that may subvert or overcome drug-resistance. Deployment of plant-based molecules in therapeutic engagements is regarded to be the most apt approach to combat different forms of leukemia. Diterpenoids of natural origin have a broad range of therapeutic activities including anti-leukemic effect. In vitro and in vivo studies establish many diterpenoids from natural sources and their synthetic derivatives to have appreciable cytotoxic and apoptotic efficacies against a series of leukemic cells. This paper attempts to identify and describe diterpenoids with their plant sources and analyze the molecular mechanistic approaches underlying their effective apoptotic activities against leukemic cells studied till date. The present review article summarizes different categories of diterpenoids having various degrees of anti-leukemic activities and discusses the measures of overcoming the bio-availability issues of these natural molecules so that they can serve as extremely viable options in future leukemia therapy.
Keywords: Anti-cancer, apoptosis, cytotoxicity, diterpenoid, growth inhibition, leukemia.
Current Pharmaceutical Biotechnology
Title:Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia
Volume: 15 Issue: 2
Author(s): Swadesh Sarkar, Priya K. Gopal and Santanu Paul
Affiliation:
Keywords: Anti-cancer, apoptosis, cytotoxicity, diterpenoid, growth inhibition, leukemia.
Abstract: Leukemia remains a major cause of death in both developing as well as developed nations worldwide. Development of novel therapeutic approaches is perceived to be the best strategy to combat this disease. Availability of limited effective drugs with least side effects is the major hurdle in treating leukemia. Another major concern remains initiation and engagement of therapeutic strategies that may subvert or overcome drug-resistance. Deployment of plant-based molecules in therapeutic engagements is regarded to be the most apt approach to combat different forms of leukemia. Diterpenoids of natural origin have a broad range of therapeutic activities including anti-leukemic effect. In vitro and in vivo studies establish many diterpenoids from natural sources and their synthetic derivatives to have appreciable cytotoxic and apoptotic efficacies against a series of leukemic cells. This paper attempts to identify and describe diterpenoids with their plant sources and analyze the molecular mechanistic approaches underlying their effective apoptotic activities against leukemic cells studied till date. The present review article summarizes different categories of diterpenoids having various degrees of anti-leukemic activities and discusses the measures of overcoming the bio-availability issues of these natural molecules so that they can serve as extremely viable options in future leukemia therapy.
Export Options
About this article
Cite this article as:
Sarkar Swadesh, Gopal K. Priya and Paul Santanu, Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia, Current Pharmaceutical Biotechnology 2014; 15 (2) . https://dx.doi.org/10.2174/1389201015666140604121658
DOI https://dx.doi.org/10.2174/1389201015666140604121658 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
[131I]IAZA as a Molecular Radiotherapeutic (MRT) Drug: Wash-Out with Cold IAZA Accelerates Clearance in a Murine Tumor Model
Current Radiopharmaceuticals ING Proteins as Potential Anticancer Drug Targets
Current Drug Targets A Review on Rheumatoid Arthritis Interventions and Current Developments
Current Drug Targets Recent Developments in Nano-Drug Delivery Systems Loaded by Phytochemicals for Wound Healing
Mini-Reviews in Medicinal Chemistry Ca<sup>2+</sup> Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
Current Vascular Pharmacology Pattern of Care for Skin Cancers - Canada and France
Current Cancer Therapy Reviews 2D, 3D, G-QSAR and Docking Studies of Thiazolyl-pyrazoline Analogues as Potent (Epidermal Growth Factor Receptor-tyrosine Kinase) EGFR-TK Inhibitors
Letters in Drug Design & Discovery Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer
Anti-Cancer Agents in Medicinal Chemistry Formulation Development of Chitosan Coated Intra Nasal Ropinirole Nanoemulsion for Better Management Option of Parkinson: An In Vitro Ex Vivo Evaluation
Current Nanoscience Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
Current Pharmaceutical Biotechnology Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry Glucose Transporters in Sex Steroid Hormone Related Cancer
Current Vascular Pharmacology Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology
Current Drug Metabolism Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances
Current Cancer Therapy Reviews Molecular Dynamics Simulations of Proteins and Peptides: From Folding to Drug Design
Current Protein & Peptide Science New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumors by Plant Polyphenols: A Critical Review
Current Medicinal Chemistry